Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA

Identifieur interne : 001710 ( Main/Exploration ); précédent : 001709; suivant : 001711

Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA

Auteurs : Angela M. Keuling [Canada] ; Susan E. Andrew [Canada] ; Victor A. Tron [Canada]

Source :

RBID : ISTEX:B5FB03B2159F9FFC076E666958D92093262D4F68

English descriptors

Abstract

The mitogen‐activated protein kinase (MAPK) pathway is constitutively activated in the majority of melanomas, promoting cell survival, proliferation and migration. In addition, anti‐apoptotic Bcl‐2 family proteins Mcl‐1, Bcl‐xL and Bcl‐2 are frequently overexpressed, contributing to melanoma’s well‐documented chemoresistance. Recently, it was reported that the combination of MAPK pathway inhibition by specific MEK inhibitors and Bcl‐2 family inhibition by BH3‐mimetic ABT‐737 synergistically induces apoptotic cell death in melanoma cell lines. Here we provide the first evidence that inhibition of another key MAPK, p38, synergistically induces apoptosis in melanoma cells in combination with ABT‐737. We also provide novel mechanistic data demonstrating that inhibition of p38 increases expression of pro‐apoptotic Bcl‐2 protein PUMA. Furthermore, we demonstrate that PUMA can be cleaved by a caspase‐dependent mechanism during apoptosis and identify what appears to be the PUMA cleavage product. Thus, our findings suggest that the combination of ABT‐737 and inhibition of p38 is a promising, new treatment strategy that acts through a novel PUMA‐dependent mechanism.

Url:
DOI: 10.1111/j.1755-148X.2010.00698.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA</title>
<author>
<name sortKey="Keuling, Angela M" sort="Keuling, Angela M" uniqKey="Keuling A" first="Angela M." last="Keuling">Angela M. Keuling</name>
</author>
<author>
<name sortKey="Andrew, Susan E" sort="Andrew, Susan E" uniqKey="Andrew S" first="Susan E." last="Andrew">Susan E. Andrew</name>
</author>
<author>
<name sortKey="Tron, Victor A" sort="Tron, Victor A" uniqKey="Tron V" first="Victor A." last="Tron">Victor A. Tron</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B5FB03B2159F9FFC076E666958D92093262D4F68</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1111/j.1755-148X.2010.00698.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-G68R1MXB-H/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002142</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002142</idno>
<idno type="wicri:Area/Istex/Curation">002142</idno>
<idno type="wicri:Area/Istex/Checkpoint">000655</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000655</idno>
<idno type="wicri:doubleKey">1755-1471:2010:Keuling A:inhibition:of:p</idno>
<idno type="wicri:Area/Main/Merge">001713</idno>
<idno type="wicri:Area/Main/Curation">001710</idno>
<idno type="wicri:Area/Main/Exploration">001710</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA</title>
<author>
<name sortKey="Keuling, Angela M" sort="Keuling, Angela M" uniqKey="Keuling A" first="Angela M." last="Keuling">Angela M. Keuling</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Department of Medical Genetics, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Andrew, Susan E" sort="Andrew, Susan E" uniqKey="Andrew S" first="Susan E." last="Andrew">Susan E. Andrew</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Department of Medical Genetics, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tron, Victor A" sort="Tron, Victor A" uniqKey="Tron V" first="Victor A." last="Tron">Victor A. Tron</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario</wicri:regionArea>
<orgName type="university">Université Queen's</orgName>
<placeName>
<settlement type="city">Kingston (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Pigment Cell & Melanoma Research</title>
<title level="j" type="alt">PIGMENT CELL MELANOMA RESEARCH</title>
<idno type="ISSN">1755-1471</idno>
<idno type="eISSN">1755-148X</idno>
<imprint>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="430">430</biblScope>
<biblScope unit="page" to="440">440</biblScope>
<biblScope unit="page-count">11</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2010-06">2010-06</date>
</imprint>
<idno type="ISSN">1755-1471</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1755-1471</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Ammonium chloride</term>
<term>Apoptosis</term>
<term>Apoptotic</term>
<term>Apoptotic cell death</term>
<term>Assay</term>
<term>Caspase</term>
<term>Caspase cleavage</term>
<term>Cell death</term>
<term>Cell lines</term>
<term>Cell survival</term>
<term>Cleavage</term>
<term>Combination treatment</term>
<term>Combination treatments</term>
<term>Cutaneous melanoma</term>
<term>Dos</term>
<term>Dsirna</term>
<term>Dsirna combination</term>
<term>Enantiomer</term>
<term>Enantiomer control</term>
<term>Family members</term>
<term>Family proteins</term>
<term>Future studies</term>
<term>Imvi</term>
<term>Imvi cells</term>
<term>Inhibition</term>
<term>Inhibitor</term>
<term>John wiley sons</term>
<term>Keuling</term>
<term>Knockdown</term>
<term>Malignant melanoma</term>
<term>Mapk</term>
<term>Melanoma</term>
<term>Melanoma cell lines</term>
<term>Melanoma cells</term>
<term>Metastatic melanoma</term>
<term>Pathway</term>
<term>Proteasome</term>
<term>Proteasome inhibitors</term>
<term>Protein puma</term>
<term>Puma</term>
<term>Puma knockdown</term>
<term>Puma levels</term>
<term>Single treatment</term>
<term>Sirna</term>
<term>Supplementary figure</term>
<term>Synergistic effect</term>
<term>Treatment response</term>
<term>Triple combination</term>
<term>Viability</term>
<term>Western immunoblots</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The mitogen‐activated protein kinase (MAPK) pathway is constitutively activated in the majority of melanomas, promoting cell survival, proliferation and migration. In addition, anti‐apoptotic Bcl‐2 family proteins Mcl‐1, Bcl‐xL and Bcl‐2 are frequently overexpressed, contributing to melanoma’s well‐documented chemoresistance. Recently, it was reported that the combination of MAPK pathway inhibition by specific MEK inhibitors and Bcl‐2 family inhibition by BH3‐mimetic ABT‐737 synergistically induces apoptotic cell death in melanoma cell lines. Here we provide the first evidence that inhibition of another key MAPK, p38, synergistically induces apoptosis in melanoma cells in combination with ABT‐737. We also provide novel mechanistic data demonstrating that inhibition of p38 increases expression of pro‐apoptotic Bcl‐2 protein PUMA. Furthermore, we demonstrate that PUMA can be cleaved by a caspase‐dependent mechanism during apoptosis and identify what appears to be the PUMA cleavage product. Thus, our findings suggest that the combination of ABT‐737 and inhibition of p38 is a promising, new treatment strategy that acts through a novel PUMA‐dependent mechanism.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Kingston (Ontario)</li>
</settlement>
<orgName>
<li>Université Queen's</li>
</orgName>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Keuling, Angela M" sort="Keuling, Angela M" uniqKey="Keuling A" first="Angela M." last="Keuling">Angela M. Keuling</name>
</noRegion>
<name sortKey="Andrew, Susan E" sort="Andrew, Susan E" uniqKey="Andrew S" first="Susan E." last="Andrew">Susan E. Andrew</name>
<name sortKey="Tron, Victor A" sort="Tron, Victor A" uniqKey="Tron V" first="Victor A." last="Tron">Victor A. Tron</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001710 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001710 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B5FB03B2159F9FFC076E666958D92093262D4F68
   |texte=   Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021